MRI Biomarkers in Assessing Articular Cartilage Health
评估关节软骨健康的 MRI 生物标志物
基本信息
- 批准号:7920168
- 负责人:
- 金额:$ 23.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteBenchmarkingBiochemicalBiochemistryBiological MarkersBiomechanicsBiometryCartilageCartilage injuryChondrocytesClinicClinicalCollagenCompetenceContrast MediaContusionsCytoskeletonDefectDegenerative polyarthritisDiagnosticElementsEnvironmentEvaluationEventExtracellular MatrixFluorescenceGadoliniumGoldHarvestHealthImageImageryInjuryJointsKneeMagnetic Resonance ImagingMapsMeasurementMeasuresMechanicsMethodsMetricModelingMonitorMorphologyOperative Surgical ProceduresOutcomeOutcome MeasurePatientsPhysiologic pulsePhysiologicalPositioning AttributePreparationProcessPropertyProspective StudiesProteoglycanProtocols documentationRandomizedRehabilitation OutcomeRehabilitation therapyRelaxationResearchResearch PersonnelSeriesSignal TransductionSiteSpecimenSynovial FluidTechniquesTestingTimeTissuesTranslational ResearchTreatment EffectivenessWateranterior cruciate ligament reconstructionanterior cruciate ligament rupturearticular cartilagebaseboneimprovedin vivoindexinginjuredjoint injurynovel strategiesprogramstreatment planninguptake
项目摘要
Magnetic resonance imaging (MRI) maintains its position as the gold standard for visualization of cartilage
defects and overall assessment of cartilage morphology. However, the earliest markers of cartilage
degeneration occur at the tissue level and are therefore not detectable as changes in morphology. At
present, there exists no effective way to objectively assess this element of cartilage health noninvasively.
The lack of quantitative measures of cartilage condition hampers treatment planning and meaningful
assessment of joint injuries. Numerous MR-based methods have been proposed to noninvasively display
and quantitate changes in the composition and integrity of such elements of cartilage extracellular matrix
(ECM) as proteoglycan (PG) and collagen content in vivo. Among techniques that have been applied in
clinical subjects, T2 MRI is sensitive to several processes involved in cartilage degeneration. Delayed
Gadolinium-enhanced MRI of cartilage (dGEMRIC) provides an index that is most directly correlated to PG
content, but relies on the selective uptake of intravenously administered contrast agent. T1rho MRI utilizes
magnetization preparation pulses without contrast administration, to yield parametric maps that also
correlate strongly with PG content. Clinical interpretation of MRI biochemical metrics is still unproven, either
by clinical or by benchtop MRI-biochemistry studies. No studies have directly compared MRI measurements
in the clinic (in vivo) with MRI-biochemistry-biomechanics measurements on that same tissue in the research
environment (ex vivo), to build a bridge for direct translation of research results to clinical interpretation. The
research here proposed will test the hypothesis that noninvasive PG-sensitive MRI in combination with
water/collagen-sensitive MRI provides an early diagnostic measure of cartilage condition after acute injury
and at 2 years post-injury, as an objective evaluation of joint and articular health. We propose SA1) to
directly quantify the concordance between PG-sensitive in vivo clinical MRI and ex vivo MRI biochemical
metrics with histochemical, biochemical, and biomechanical measurements within articular cartilage
sections; SA2) to demonstrate a combination of T1rho/T2 relaxation sequence metrics as a biomarkerto
assess cartilage health and mechanical function, SA3); to apply T1rho/T2 MRI clinically at time of injury as a
benchmark for acute post-injury treatment effectiveness, and as a rehabilitation and outcomes measure.
磁共振成像(MRI)保持了其作为软骨可视化金标准的地位
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Douglas Ray Pedersen其他文献
Douglas Ray Pedersen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Douglas Ray Pedersen', 18)}}的其他基金
Establishing Treatments and Diagnostic Tools for Post-Traumatic OA in Vivo
在体内建立创伤后 OA 的治疗方法和诊断工具
- 批准号:
8539464 - 财政年份:2013
- 资助金额:
$ 23.56万 - 项目类别:
Establishing Treatments and Diagnostic Tools for Post-Traumatic OA in Vivo
在体内建立创伤后 OA 的治疗方法和诊断工具
- 批准号:
8345674 - 财政年份:2012
- 资助金额:
$ 23.56万 - 项目类别:
MRI Biomarkers in Assessing Articular Cartilage Health
评估关节软骨健康的 MRI 生物标志物
- 批准号:
7677865 - 财政年份:2008
- 资助金额:
$ 23.56万 - 项目类别:
MRI Biomarkers in Assessing Articular Cartilage Health
评估关节软骨健康的 MRI 生物标志物
- 批准号:
7347196 - 财政年份:2007
- 资助金额:
$ 23.56万 - 项目类别:
MRI Biomarkers in Assessing Articular Cartilage Health
评估关节软骨健康的 MRI 生物标志物
- 批准号:
8128417 - 财政年份:
- 资助金额:
$ 23.56万 - 项目类别:
Establishing Treatments and Diagnostic Tools for Post-Traumatic OA in Vivo
在体内建立创伤后 OA 的治疗方法和诊断工具
- 批准号:
8925774 - 财政年份:
- 资助金额:
$ 23.56万 - 项目类别:
Establishing Treatments and Diagnostic Tools for Post-Traumatic OA in Vivo
在体内建立创伤后 OA 的治疗方法和诊断工具
- 批准号:
9133275 - 财政年份:
- 资助金额:
$ 23.56万 - 项目类别:
MRI Biomarkers in Assessing Articular Cartilage Health
评估关节软骨健康的 MRI 生物标志物
- 批准号:
8324139 - 财政年份:
- 资助金额:
$ 23.56万 - 项目类别:
相似国自然基金
企业绩效评价的DEA-Benchmarking方法及动态博弈研究
- 批准号:70571028
- 批准年份:2005
- 资助金额:16.5 万元
- 项目类别:面上项目
相似海外基金
An innovative EDI data, insights & peer benchmarking platform enabling global business leaders to build data-led EDI strategies, plans and budgets.
创新的 EDI 数据、见解
- 批准号:
10100319 - 财政年份:2024
- 资助金额:
$ 23.56万 - 项目类别:
Collaborative R&D
BioSynth Trust: Developing understanding and confidence in flow cytometry benchmarking synthetic datasets to improve clinical and cell therapy diagnos
BioSynth Trust:发展对流式细胞仪基准合成数据集的理解和信心,以改善临床和细胞治疗诊断
- 批准号:
2796588 - 财政年份:2023
- 资助金额:
$ 23.56万 - 项目类别:
Studentship
Collaborative Research: SHF: Medium: A Comprehensive Modeling Framework for Cross-Layer Benchmarking of In-Memory Computing Fabrics: From Devices to Applications
协作研究:SHF:Medium:内存计算结构跨层基准测试的综合建模框架:从设备到应用程序
- 批准号:
2347024 - 财政年份:2023
- 资助金额:
$ 23.56万 - 项目类别:
Standard Grant
Elements: CausalBench: A Cyberinfrastructure for Causal-Learning Benchmarking for Efficacy, Reproducibility, and Scientific Collaboration
要素:CausalBench:用于因果学习基准测试的网络基础设施,以实现有效性、可重复性和科学协作
- 批准号:
2311716 - 财政年份:2023
- 资助金额:
$ 23.56万 - 项目类别:
Standard Grant
Benchmarking collisional rates and hot electron transport in high-intensity laser-matter interaction
高强度激光-物质相互作用中碰撞率和热电子传输的基准测试
- 批准号:
2892813 - 财政年份:2023
- 资助金额:
$ 23.56万 - 项目类别:
Studentship
FET: Medium: Quantum Algorithms, Complexity, Testing and Benchmarking
FET:中:量子算法、复杂性、测试和基准测试
- 批准号:
2311733 - 财政年份:2023
- 资助金额:
$ 23.56万 - 项目类别:
Continuing Grant
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
- 批准号:
2233969 - 财政年份:2023
- 资助金额:
$ 23.56万 - 项目类别:
Continuing Grant
Establishing and benchmarking advanced methods to comprehensively characterize somatic genome variation in single human cells
建立先进方法并对其进行基准测试,以全面表征单个人类细胞的体细胞基因组变异
- 批准号:
10662975 - 财政年份:2023
- 资助金额:
$ 23.56万 - 项目类别:
QUARREFOUR - Benchmarking Multi-core Quantum Computing Systems
QUARREFOUR - 多核量子计算系统基准测试
- 批准号:
10074653 - 财政年份:2023
- 资助金额:
$ 23.56万 - 项目类别:
Collaborative R&D